8C73.1

ICD-11 MMS 2026-01

Neuropathy, ataxia, and retinitis pigmentosa

Description

Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP) syndrome is a clinically heterogeneous oxidative phosphorylation disorder often characterised by a combination of sensory-motor neuropathy, cerebellar ataxia, and night blindness.

Index terms

  • Neuropathy, ataxia, and retinitis pigmentosa
  • NARP - [Neuropathy, ataxia and retinitis pigmentosa] syndrome
  • Neurogenic muscle weakness, ataxia, and retinitis pigmentosa

Exclusions from above levels

  • http://id.who.int/icd/entity/155258022 – Metabolic disorders
  • LD26.41 – Arthrogryposis multiplex congenita
  • 05 – Endocrine, nutritional or metabolic diseases
Show allHide
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 19 – Certain conditions originating in the perinatal period
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • 8C73.0 – Autosomal recessive cardiomyopathy or ophthalmoplegia
  • 8C73.Y – Other specified mitochondrial myopathies
  • 8C73.Z – Mitochondrial myopathies, unspecified

Foundation entity

Neuropathy, ataxia, and retinitis pigmentosa – http://id.who.int/icd/entity/2089784682

Part of: 8C73: Mitochondrial myopathies › 08: Diseases of the nervous system